Abstract
Ovarian cancer affects over 25,000 women each year in the United States. The performance of appropriate surgery for ovarian cancer is critical in directing further therapies and improving survival. Systematic surgical staging must be performed in patients who appear to have early stage ovarian cancer because a significant proportion of these women have occult metastases. A marked improvement in survival has been demonstrated in patients with bulky disease if all masses larger than 2 cm can be surgically removed. Despite the dramatic effect of surgery on the subsequent course of the disease, recent studies show that only a minority of women with ovarian cancer receive appropriate initial surgery. We review the evidence and rationale for systematic surgical treatment of ovarian cancer.
Original language | English |
---|---|
Pages (from-to) | 173-180 |
Number of pages | 8 |
Journal | Seminars in Surgical Oncology |
Volume | 17 |
Issue number | 3 |
DOIs | |
State | Published - Oct 1999 |
Keywords
- Adenocarcinoma
- Adnexal diseases
- Biopsy
- CA- 125 antigen
- Combined antineoplastic agents
- Laparoscopy
- Lymph nodes
- Mass screening
- Neoplasm metastasis
- Neoplasm staging
- Ovarian neoplasms/etiology/diagnosis/surgery/pathology/drug therapy
- Quality of life
- Survival rate